Trials / Completed
CompletedNCT05898113
Effect of the Intake of Corbella Extra Virgin Olive Oil on the Microbiota-gut-brain Axis in Healthy Adults (HEVOOC)
Development of Oil with Healthy Properties Based on Corbella Olive Variety (HEVOOC)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- University of Barcelona · Academic / Other
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
The consumption of the improved extra virgin olive oil (EVOO) of the Corbella variety could have a beneficial effect on the microbiota-intestine-brain axis (MGBA). Olive oil contains polyphenols that are not present in other oils, notably oleocanthal and oleacein, which behave similarly to ibuprofen and have a protective effect on some neurodegenerative diseases. The polyphenols of the oil present prebiotic characteristics, at the level of the intestinal microbiota, which metabolizes them forming bioactive metabolites that can have a modulating effect on the MGBA, improving brain health. In this study, the researchers seek to identify the benefits of the consumption of Corbella variety EVOO on MGBA in healthy participants. The overall benefit of the study would be to achieve knowledge that would allow its future applicability to prevent and improve certain diseases and in general contribute to optimal health.
Detailed description
To evaluate possible effects on MGBA, a randomized, controlled, crossover nutritional trial will be conducted. Thirty healthy adult participants (between 18 and 35 years of age, with 50% male and 50% female) will be included according to the estimated sample size. Participants will consume a daily amount of 0.7 g Corbella EVOO/kg body weight plus their normal diet (experimental intervention) and 0.7 g refined olive oil (ROO)/kg body weight plus their normal diet (control intervention) for 1 month. Biological samples (plasma, peripheral blood mononuclear cells, serum, 24-hour urine, feces and saliva) will be obtained at baseline and at the end of each trial arm.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | EXTRA VIRGIN OLIVE OIL | Participants will consume a daily amount of extra virgin olive oil. Can consume the oil either raw or cooked |
| OTHER | OLIVE OIL LOW POLYPHENOL | Participants will consume a daily amount of olive oil low polyphenol. Can consume the oil either raw or cooked |
Timeline
- Start date
- 2023-06-19
- Primary completion
- 2023-08-10
- Completion
- 2023-11-24
- First posted
- 2023-06-12
- Last updated
- 2025-04-01
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05898113. Inclusion in this directory is not an endorsement.